Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 4 pages · Chinese
Summary by 6ix AI
Dizal (Jiangsu) Pharmaceutical Co. Ltd. has announced abnormal fluctuations in its stock trading, with significant price changes over three consecutive trading days. The announcement includes a reminder for investors to be cautious due to the uncertainties surrounding the agreement's effectiveness and the drug's market approval process. The board assures that there are no undisclosed significant matters affecting the company at this time.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/dizal-pharmaceutical-co-ltdannouncement-on-abnormal-fluctuations-in-stock-trading
Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix
Earlier from Dizal (Jiangsu) Pharmaceutical
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Voluntary Disclosure of Multiple Latest Research Advances in Lung Cancer at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
- Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
- Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
- Announcement on Voluntary Disclosure of the Acceptance of the New Drug Application for Sunvozertinib as First-Line Monotherapy for EGFR Exon20ins Non-Small Cell Lung Cancer by the National Medical Products Administration and Its Inclusion in Priority Review
Later from Dizal (Jiangsu) Pharmaceutical
- Materials for the 2nd Extraordinary General Meeting in 2026
- Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Providing Guarantee for Controlled Subsidiary
- Announcement on Resolutions of the 1st Meeting of the 3rd Board of Directors
Follow Dizal (Jiangsu) Pharmaceutical into a list and get an email when it puts out news.
Follow Dizal (Jiangsu) Pharmaceutical